+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor



Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor



Biological Psychiatry 14(3): 509-523



Lumbar CSF HVA, MHPG, 5HIAA, cAMP, and cGMP were measured in 12 chronic schizophrenics with tardive dyskinesia before and 3 weeks after sodium valproate (VPA) or cyproheptadine treatment. HVA levels significantly decreased and cAMP and cGMP levels significantly increased during the administration of VPA or cyproheptadine. There were no significant correlations between the degree of improvement in tardive dyskinesia and the changes of amine metabolities or cyclic nucleotides. None of the pretreatment values for CSF amine metabolites or cyclic nucleotides were different from those of 15 chronic schizophrenics without tardive dyskinesia as controls. Decrease of HVA and increase of cGMP during the treatment might indicate the normalization of dopaminergic-cholinergic imbalance in the brain. Furthermore, significantly low levels of 5HIAA were observed in the patients with drug-induced tremor. It is suggested that neuroleptic-induced tremor may be attributed to serotonergic dysfunction in the brain.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 038919911

Download citation: RISBibTeXText

PMID: 38867


Related references

Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid. Clinical Therapeutics 7 Spec No: 1-17, 1984

Tardive dyskinesia and neurotransmitters effects of sodium valproate cyproheptadine oxypertine hydroxyzine pamoate and calcium hopantenate on monoamine metabolites cyclic nucleotides and gamma aminobutyric acid in human cerebrospinal fluid. Clinical Therapeutics 7(SPEC ISSUE): 1-17, 1984

Cerebro spinal fluid mono amine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dys kinesia. Neurochemical Research 3(5): 654, 1978

Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy. No to Shinkei 31(12): 1225-1231, 1979

Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism. Japanese Journal of Psychiatry and Neurology 40(2): 189-194, 1986

Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning. Archiv für Psychiatrie und Nervenkrankheiten 226(3): 173-181, 1978

Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia. Acta Psychiatrica Scandinavica 46(4): 323-326, 1970

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research 9(4): 301-308, 1983

An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patients. Life Sciences 19(1): 131-136, 1976

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. British Journal of Psychiatry 147: 276-282, 1985

Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Journal of Clinical Psychiatry 58(7): 318-322, 1997

Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients. Psychopharmacology 62(1): 17-22, 1979

Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia. Psychopharmacology 84(3): 436-440, 1984

Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug. World Journal of Biological Psychiatry 10(4 Pt 3): 919-924, 2009

Cyclic Nucleotides in Cerebrospinal Fluid of Drug-Free Parkinson Patients. European Neurology 27(1): 24-28, 1987